Literature DB >> 8377747

Movement disorders.

F Cardoso1, J Jankovic.   

Abstract

This article focuses on the current knowledge about movement disorders associated with alcohol and drug abuse. Chronic alcohol use can produce a wide spectrum of movement disorders including tremor, withdrawal parkinsonism and dyskinesias, cerebellar ataxia, and asterixis. MPTP, a neurotoxin first reported to cause parkinsonism in a group of drug abusers, has provided important insights into the pathogenesis of Parkinson's disease. There is a growing body of literature providing evidence that dyskinesias such as tics and dystonia may be precipitated or exacerbated by cocaine. Amphetamines have been implicated in the production of stereotypies and exacerbation of tics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377747

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  5 in total

1.  Cocaine induced chronic tics.

Authors:  E Attig; R Amyot; T Botez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

2.  Substance Use Disorders and Neurologic Illness.

Authors:  Robert D. Davies; Christian Thurstone; Kelly Woyewodzic
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

3.  Illicit stimulant use in humans is associated with a long-term increase in tremor.

Authors:  Stanley C Flavel; Jenna D Koch; Jason M White; Gabrielle Todd
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

4.  Hand function is altered in individuals with a history of illicit stimulant use.

Authors:  Verity Pearson-Dennett; Stanley C Flavel; Robert A Wilcox; Dominic Thewlis; Adam P Vogel; Jason M White; Gabrielle Todd
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

5.  Tourette syndrome and klippel-feil anomaly in a child with chromosome 22q11 duplication.

Authors:  Raymond A Clarke; Zhi Ming Fang; Ashish D Diwan; Donald L Gilbert
Journal:  Case Rep Med       Date:  2009-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.